Hermansky-Pudlak syndrome (HPS)
Hermansky-Pudlak syndrome (HPS) is a rare syndrome which consists of:
- oculocutaneous hypopigmentation (albinism)
- platelet dysfunction
- abnormal storage of autofluorescent pigment (ceroid or lipofuscin)
- typically occurs within lysosomal organelles of the cells of multiple organs and the reticuloendothelial system
Epidemiology
There is a recognized regional predilection with increased incidence around the Swiss alps region and in Puerto Rico .
Pathology
Genetics
The condition is a genetically transmitted autosomal recessive disorder. At least six distinct genetic forms (HPS1 through HPS6) have been identified resulting in somewhat different clinical manifestations.
Complications
- pulmonary fibrosis
- considered a frequent complication
- incidence and severity of fibrosis is greatest in patients with HPS1 and HPS4
- slowly progressive lung fibrosis occurs in individuals aged 20-40 years
- granulomatous colitis
- patients with HPS can occasionally develop granulomatous colitis similar to Crohn disease
- believed to be a result of an accumulation of ceroid or lipofuscin in the bowel wall
- small bowel involvement is only rarely involved
History and etymology
It was initially described by F Hermansky and P Pudlak in 1959 .
See also
- Chédiak-Higashi syndrome, similar syndrome but has:
- recurrent childhood infection
- peripheral and central neuropathy
- accelerated phase
Siehe auch:
